These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 21788701

  • 1. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan.
    Sato T, Nakagomi T, Nakagomi O.
    Jpn J Infect Dis; 2011; 64(4):277-83. PubMed ID: 21788701
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR.
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of a pentavalent rotavirus vaccine in Japan.
    Itzler R, O'Brien MA, Yamabe K, Abe M, Dhankhar P.
    J Med Econ; 2013 Oct; 16(10):1216-27. PubMed ID: 23919721
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The incidence and direct medical cost of hospitalization due to rotavirus gastroenteritis in Kyoto, Japan, as estimated from a retrospective hospital study.
    Ito H, Otabe O, Katsumi Y, Matsui F, Kidowaki S, Mibayashi A, Nakagomi T, Nakagomi O.
    Vaccine; 2011 Oct 13; 29(44):7807-10. PubMed ID: 21821087
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Economic evaluation of routine infant rotavirus immunisation program in Japan.
    Hoshi SL, Kondo M, Okubo I.
    Hum Vaccin Immunother; 2017 May 04; 13(5):1115-1125. PubMed ID: 27763810
    [Abstract] [Full Text] [Related]

  • 12. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O, El-Sayed N, Sanders JW, Abd-Rabou Z, Antil L, Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
    Wu CL, Yang YC, Huang LM, Chen KT.
    Vaccine; 2009 Mar 04; 27(10):1492-9. PubMed ID: 19186200
    [Abstract] [Full Text] [Related]

  • 16. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
    Bar-Zeev N, Tate JE, Pecenka C, Chikafa J, Mvula H, Wachepa R, Mwansambo C, Mhango T, Chirwa G, Crampin AC, Parashar UD, Costello A, Heyderman RS, French N, Atherly D, Cunliffe NA, VACSURV Consortium.
    Clin Infect Dis; 2016 May 01; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece.
    Syriopoulou V, Kafetzis D, Theodoridou M, Syrogiannopoulos GA, Mantagos S, Trimis G, Mavrikou M, Konstantopoulos A.
    Acta Paediatr; 2011 May 01; 100(5):732-9. PubMed ID: 21223372
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option.
    Cui S, Tobe RG, Mo X, Liu X, Xu L, Li S.
    BMC Infect Dis; 2016 Nov 15; 16(1):677. PubMed ID: 27846803
    [Abstract] [Full Text] [Related]

  • 19. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H, Levybruhl D, Boelle PY, Dervaux B, Baron S, Yazdanpanah Y.
    Vaccine; 2008 Jan 30; 26(5):706-15. PubMed ID: 18166250
    [Abstract] [Full Text] [Related]

  • 20. Should rotavirus vaccines be included in the national immunization program of a small developed country?
    Milne R, Grimwood K.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct 30; 9(5):401-4. PubMed ID: 19817522
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.